Literature DB >> 28832876

Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Stephen T Higgins1, Sarah H Heil1, Stacey C Sigmon1, Jennifer W Tidey2, Diann E Gaalema1, John R Hughes1, Maxine L Stitzer3, Hanna Durand1, Janice Y Bunn1, Jeff S Priest1, Christopher A Arger1, Mollie E Miller2, Cecilia L Bergeria1, Danielle R Davis1, Joanna M Streck1, Derek D Reed4, Joan M Skelly1, Lauren Tursi1.   

Abstract

Importance: A national policy is under consideration to reduce the nicotine content of cigarettes to lower nicotine addiction potential in the United States. Objective: To examine how smokers with psychiatric disorders and other vulnerabilities to tobacco addiction respond to cigarettes with reduced nicotine content. Design, Setting, and Participants: A multisite, double-blind, within-participant assessment of acute response to research cigarettes with nicotine content ranging from levels below a hypothesized addiction threshold to those representative of commercial cigarettes (0.4, 2.3, 5.2, and 15.8 mg/g of tobacco) at 3 academic sites included 169 daily smokers from the following 3 vulnerable populations: individuals with affective disorders (n = 56) or opioid dependence (n = 60) and socioeconomically disadvantaged women (n = 53). Data were collected from March 23, 2015, through April 25, 2016. Interventions: After a brief smoking abstinence, participants were exposed to the cigarettes with varying nicotine doses across fourteen 2- to 4-hour outpatient sessions. Main Outcomes and Measures: Addiction potential of the cigarettes was assessed using concurrent choice testing, the Cigarette Purchase Task (CPT), and validated measures of subjective effects, such as the Minnesota Nicotine Withdrawal Scale.
Results: Among the 169 daily smokers included in the analysis (120 women [71.0%] and 49 men [29.0%]; mean [SD] age, 35.6 [11.4] years), reducing the nicotine content of cigarettes decreased the relative reinforcing effects of smoking in all 3 populations. Across populations, the 0.4-mg/g dose was chosen significantly less than the 15.8-mg/g dose in concurrent choice testing (mean [SEM] 30% [0.04%] vs 70% [0.04%]; Cohen d = 0.40; P < .001) and generated lower demand in the CPT (α = .027 [95% CI, 0.023-0.031] vs α = .019 [95% CI, 0.016-0.022]; Cohen d = 1.17; P < .001). Preference for higher over lower nicotine content cigarettes could be reversed by increasing the response cost necessary to obtain the higher dose (mean [SEM], 61% [0.02%] vs 39% [0.02%]; Cohen d = 0.40; P < .001). All doses reduced Minnesota Nicotine Withdrawal Scale total scores (range of mean decreases, 0.10-0.50; Cohen d range, 0.21-1.05; P < .001 for all), although duration of withdrawal symptoms was greater at higher doses (η2 = 0.008; dose-by-time interaction, P = .002). Conclusions and Relevance: Reducing the nicotine content of cigarettes may decrease their addiction potential in populations that are highly vulnerable to tobacco addiction. Smokers with psychiatric conditions and socioeconomic disadvantage are more addicted and less likely to quit and experience greater adverse health impacts. Policies to reduce these disparities are needed; reducing the nicotine content in cigarettes should be a policy focus.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28832876      PMCID: PMC5710465          DOI: 10.1001/jamapsychiatry.2017.2355

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  37 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients.

Authors:  E A Jacobs; W K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

3.  Behavioral economics of drug self-administration. II. A unit-price analysis of cigarette smoking.

Authors:  W K Bickel; R J DeGrandpre; J R Hughes; S T Higgins
Journal:  J Exp Anal Behav       Date:  1991-03       Impact factor: 2.468

4.  Further validation of a cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers.

Authors:  James MacKillop; James G Murphy; Lara A Ray; Daniel T A Eisenberg; Stephen A Lisman; J Koji Lum; David S Wilson
Journal:  Exp Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.157

5.  Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.

Authors:  Christopher G AhnAllen; L Cinnamon Bidwell; Jennifer W Tidey
Journal:  Nicotine Tob Res       Date:  2014-08-20       Impact factor: 4.244

6.  American health improvement depends upon addressing class disparities.

Authors:  Steven A Schroeder
Journal:  Prev Med       Date:  2016-03-24       Impact factor: 4.018

7.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

8.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

9.  Smoking and mental illness: results from population surveys in Australia and the United States.

Authors:  David Lawrence; Francis Mitrou; Stephen R Zubrick
Journal:  BMC Public Health       Date:  2009-08-07       Impact factor: 3.295

Review 10.  Smoking cessation and reduction in people with chronic mental illness.

Authors:  Jennifer W Tidey; Mollie E Miller
Journal:  BMJ       Date:  2015-09-21
View more
  63 in total

1.  Comparing participant estimated demand intensity on the cigarette Purchase Task to consumption when usual-brand cigarettes were provided free.

Authors:  Tyler D Nighbor; Anthony J Barrows; Janice Y Bunn; Michael J DeSarno; Anthony C Oliver; Sulamunn R M Coleman; Danielle R Davis; Joanna M Streck; Ellaina N Reed; Derek D Reed; Stephen T Higgins
Journal:  Prev Med       Date:  2020-07-24       Impact factor: 4.018

2.  Validation of a behavioral economic purchase task for assessing drug abuse liability.

Authors:  James MacKillop; Nicholas I Goldenson; Matthew G Kirkpatrick; Adam M Leventhal
Journal:  Addict Biol       Date:  2018-01-05       Impact factor: 4.280

3.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

4.  The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller.

Authors:  Dorothy K Hatsukami; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Tobacco and nicotine delivery product use in a U.S. national sample of women of reproductive age.

Authors:  Alexa A Lopez; Ryan Redner; Allison N Kurti; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Janice Y Bunn; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Stephen T Higgins
Journal:  Prev Med       Date:  2018-03-17       Impact factor: 4.018

Review 6.  A review of tobacco regulatory science research on vulnerable populations.

Authors:  Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton
Journal:  Prev Med       Date:  2019-05-02       Impact factor: 4.018

7.  Modeling smoking-attributable mortality among adults with major depression in the United States.

Authors:  Jamie Tam; Gemma M J Taylor; Kara Zivin; Kenneth E Warner; Rafael Meza
Journal:  Prev Med       Date:  2020-08-27       Impact factor: 4.018

8.  Examining the relationship between pregnancy and quitting use of tobacco products in a U.S. national sample of women of reproductive age.

Authors:  Allison N Kurti; Ryan Redner; Janice Y Bunn; Katherine Tang; Tyler Nighbor; Alexa A Lopez; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Julie Phillips; Maria A Parker; Amanda J Quisenberry; Stephen T Higgins
Journal:  Prev Med       Date:  2018-08-23       Impact factor: 4.018

9.  Impact of Brief Nicotine Messaging on Nicotine-Related Beliefs in a U.S. Sample.

Authors:  Andrea C Villanti; Julia C West; Darren Mays; Eric C Donny; Joseph N Cappella; Andrew A Strasser
Journal:  Am J Prev Med       Date:  2019-10       Impact factor: 5.043

10.  Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.

Authors:  Tracy T Smith; Joseph S Koopmeiners; Katelyn M Tessier; Esa M Davis; Cynthia A Conklin; Rachel L Denlinger-Apte; Tonya Lane; Sharon E Murphy; Jennifer W Tidey; Dorothy K Hatsukami; Eric C Donny
Journal:  Am J Prev Med       Date:  2019-10       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.